CIK 0001708527
- Non-accelerated filer
- Smaller reporting company
ELUTIA INC.
Sign in to watch- Ticker
- ELUT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474790334
- Phone
- +1 240-247-1143
- Business address
- 12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRING, MD, 20904
- Former names
- AZIYO BIOLOGICS, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-09 | Englese Thomas CHIEF COMMERCIAL OFFICER | Sale | −289 | $4.30 | $1K | 17,917 |
| 2023-03-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Exercise or conversion | +937 | 18,206 | ||
| 2023-03-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Exercise or conversion · Restricted Stock Units | −937 | 1,875 | ||
| 2022-09-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Exercise or conversion | +15,390 | 21,997 | ||
| 2022-09-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −4,728 | $7.30 | $35K | 17,269 |
| 2022-09-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Exercise or conversion · Restricted Stock Units | −15,390 | 0 | ||
| 2022-03-10 | Englese Thomas CHIEF COMMERCIAL OFFICER | Sale | −276 | 6,607 | ||
| 2022-03-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Exercise or conversion | +938 | 6,883 | ||
| 2022-03-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +31,000 | 31,000 | ||
| 2022-03-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Grant or award · Restricted Stock Units | +8,700 | 8,700 | ||
| 2022-03-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Exercise or conversion · Restricted Stock Units | −938 | 2,812 | ||
| 2022-03-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Grant or award · Restricted Stock Units | +15,390 | 15,390 | ||
| 2021-12-14 | Englese Thomas CHIEF COMMERCIAL OFFICER | Purchase | +4,580 | $6.10 | $28K | 5,088 |
| 2021-03-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Grant or award · STOCK OPTION (RIGHT TO BUY) | +22,500 | 22,500 | ||
| 2021-03-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Grant or award · RESTRICTED STOCK UNITS | +3,750 | 3,750 | ||
| 2020-10-07 | Englese Thomas Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +33,488 | 33,488 | ||
| 2020-10-07 | Englese Thomas Chief Commercial Officer | Grant or award · Restricted Stock Units | +13,890 | 13,890 |
Page 1 of 1 · 17 trades